TD Cowen Downgrades BioLife Solutions to Hold, Lowers Price Target to $31

Benzinga · 1d ago
TD Cowen analyst Brendan Smith downgrades BioLife Solutions (NASDAQ:BLFS) from Buy to Hold and lowers the price target from $33 to $31.